Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

311 Views

Poster Session: COVID-19: Treatment

1129 - Efficacy of a Polyclonal Ovine Fab (PR020) Against SARS-CoV-2 Infection

Friday, October 21, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

Zainab Bascal, PhD

Early Clinical Development Director
BTG International Inc
Llandysul, Wales, United Kingdom

Co-Author(s)

AG

Aled Griffiths, BSc

Senior Manager New Target Platform Development
BTG International Inc
Llandysul, Wales, United Kingdom
ED

Ellen Dentten, PhD

Director, CMC
BTG International Inc
Llandysul, Wales, United Kingdom
CH

Christon Hill, BSc, MBA

Chief Innovation Officer
BTG International Inc
Boston, Massachusetts, United States
SW

Suzanne Ward, PharmD

Senior Director Medical Strategy
BTG International Inc
Franklin, Tennessee, United States